Varroc Engineering reports Q2 FY27 investor presentation
Varroc Engineering Limited has released its investor presentation for the second quarter and half-year ended September 30, 2026. The…
Persistent Systems approves allotment of INR 70 billion in NCDs
Persistent Systems Limited has approved the allotment of 700,000 Non-Convertible Debentures (NCDs), aggregating to INR 70 billion. These…
Balrampur Chini Mills declares ₹4 interim dividend and reports Q2 results
Balrampur Chini Mills has announced an interim dividend of ₹4 per equity share (400%) for the financial year 2026-27. This decision was made…
ICICI Securities Limited reports nil shares tendered in open offer escrow account
ICICI Securities Limited has disclosed that nil equity shares were tendered in the Open Offer Escrow Demat Account as of November 4, 2026.…
CEAT Limited files notice regarding loss of share certificates
CEAT Limited has officially notified BSE Limited and the National Stock Exchange of India Limited about the loss of share certificates…
Growington Ventures India reports financial results for Q2 FY27
Growington Ventures India Limited has officially submitted its un-audited financial results for the quarter and half-year ended September 30,…
Balrampur Chini Mills approves interim dividend and Q2 FY27 results
Balrampur Chini Mills Limited announced the approval of its un-audited financial results for the quarter and half-year ended September 30,…
C.E. Info Systems Limited approves Q2 FY27 results and appoints new senior management
C.E. Info Systems Limited (Mapmy India) announced the outcome of its Board meeting held on November 4, 2026. The board approved the Un-Audited…
Growington Ventures India reports financial results for Q2 FY27
Growington Ventures India Limited has announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The…
Alembic Pharmaceuticals expands US complex generics collaboration with DifGen
Alembic Pharmaceuticals Limited announced the expansion of its strategic collaboration with DifGen Pharmaceuticals, focusing on their complex…